StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2013 it was 100.0%, against 100.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2013Dec 31, 2013100.0%+0.0
FY2012Dec 31, 2012100.0%+0.0
FY2011Dec 31, 2011100.0%+0.0
FY2010Dec 31, 2010100.0%–

More Northwest Biotherapeutics figures

See a number that looks wrong?